why choose us

Clinical Trials Search

Showing 10,160 of 132,963 result(s)
Goal Setting to Promote Physical Activity Adherence in Midlife Adults

Status: Completed

Condition: Physical Activity

Interventions: Theory-driven behavioral physical activity promotion intervention.

Date: 2023-07-17

Effect of Virtual Reality-based Training on Balance and Walking in Youth With Autism Spectrum Disorder

Status: Completed

Condition: Autism Spectrum Disorder

Interventions: Playing 2 pre-selected VR active video games from beach tennis, soccer, volleyball, badminton, bowling, and chambara for 10 minutes each with a 5 minu

Date: 2023-07-17

NeuroGlove PTSD Study

Status: ACTIVE_NOT_RECRUITING

Condition: PTSD

Interventions: Study participant with PTSD will undergo daily at home treatment using the NeuroGlove.

Date: 2023-07-17

A Prospective Imaging Study of the Integrated TrueBeam-HyperSight CBCT System

Status: Completed

Condition: Head and Neck Cancer

Interventions: Subjects are scheduled for 1 to 5 HyperSight imaging sessions, which will occur on the same days as their standard clinical visits during planning and

Date: 2023-07-17

Comparison of Produce Prescription Benefit Dosage

Status: NOT_YET_RECRUITING

Condition: Food Insecurity

Interventions: Participants will receive varying benefit amounts to purchase fruits and vegetables.

Date: 2023-07-17

The Breakfast Study

Status: Completed

Condition: Type 2 Diabetes

Interventions: We will provide participants recipes and information to support this dietary change.

Date: 2023-07-17

Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer

Status: Completed

Condition: HER2-positive Metastatic Breast Cancer

Interventions: Patients assigned to this group will be asked to discontinue anti-HER-2 maintenance treatment.

Date: 2023-07-17

Dampening the Reproductive Axis With Continuous Kisspeptin

Status: Completed

Condition: Reproductive Disorder

Interventions: IV infusion of kisspeptin 112-121 x 24 hours; up to two IV boluses of kisspeptin

Date: 2023-07-17

Group MDMA-therapy for Veterans With PTSD

Status: Completed

Condition: PTSD

Interventions: Initial dose of 120 mg MDMA HCL and optional supplemental dose of 60 mg MDMA HCL at 1.5 to 2 hours after first dose

Date: 2023-07-17

A Relative Bioavailability Study of Peresolimab (LY3462817) Formulations in Healthy Participants

Status: Completed

Condition: Healthy

Interventions: Administered SC

Date: 2023-07-17